- Home
- TERN vs CEVA Comparison
TERN vs CEVA Comparison
Compare TERN & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- CEVA
- Stock Information
- Founded
- TERN 2017
- CEVA 1999
- Country
- TERN United States
- CEVA United States
- Employees
- TERN N/A
- CEVA N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- CEVA Semiconductors
- Sector
- TERN Health Care
- CEVA Technology
- Exchange
- TERN Nasdaq
- CEVA Nasdaq
- Market Cap
- TERN 586.0M
- CEVA 666.8M
- IPO Year
- TERN 2021
- CEVA 2000
- Fundamental
- Price
- TERN $6.17
- CEVA $27.01
- Analyst Decision
- TERN Buy
- CEVA Strong Buy
- Analyst Count
- TERN 6
- CEVA 3
- Target Price
- TERN $16.42
- CEVA $33.67
- AVG Volume (30 Days)
- TERN 1.3M
- CEVA 149.5K
- Earning Date
- TERN 11-12-2024
- CEVA 11-07-2024
- Dividend Yield
- TERN N/A
- CEVA N/A
- EPS Growth
- TERN N/A
- CEVA N/A
- EPS
- TERN N/A
- CEVA N/A
- Revenue
- TERN N/A
- CEVA $101,878,000.00
- Revenue This Year
- TERN N/A
- CEVA $9.76
- Revenue Next Year
- TERN N/A
- CEVA $10.37
- P/E Ratio
- TERN N/A
- CEVA N/A
- Revenue Growth
- TERN N/A
- CEVA N/A
- 52 Week Low
- TERN $3.59
- CEVA $16.02
- 52 Week High
- TERN $11.40
- CEVA $30.00
- Technical
- Relative Strength Index (RSI)
- TERN 31.82
- CEVA 58.68
- Support Level
- TERN $6.99
- CEVA $27.30
- Resistance Level
- TERN $7.53
- CEVA $28.33
- Average True Range (ATR)
- TERN 0.47
- CEVA 1.14
- MACD
- TERN -0.02
- CEVA 0.23
- Stochastic Oscillator
- TERN 16.57
- CEVA 55.64
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.